Journal of Controlled Release · 2023 · 35 citations · 42 references
Life SciencesMolecular BiologyNeuroscienceDementiaMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseLiposomal FormulationsLiposome-based DeliveryNanomedicineNeurodegenerative DiseasesNeurodegenerative DisordersLiposomesMicrorna TherapeuticsTargeted Liposomes
42
Lecanemab in Early Alzheimer’s Disease
Christopher H. van Dyck, Chad J. Swanson, Paul Aisen et al. · New England Journal of Medicine · 2022 · 5.2K citations · Full text